Onconova Therapeutics Inc (NASDAQ:ONTX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ONTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ONTX

  • Market Cap$53.260m
  • SymbolNASDAQ:ONTX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS68232V4059

Company Profile

Onconova Therapeutics Inc is a clinical-stage biopharmaceutical company operating in the US. It focuses on discovering and developing novel small molecule product candidates primarily to treat cancer. The company has created a library of targeted agents designed to work against cellular pathways important to cancer cells. Its product candidates are Single-agent IV rigosertib, Oral rigosertib + azacitidine, IV Briciclib, Recilisib, and ON 123300. The key product candidate Rigosertib is a small molecule which blocks signaling by targeting RAS effeccellular tor pathways.Onconova Therapeutics Inc is a biopharmaceutical company focusing on discovering and developing novel small molecule product candidates primarily to treat cancer.

Latest ONTX news

Currently there for this company. Visit our news hub for other news .